Peter Repiščák

832 total citations
13 papers, 402 citations indexed

About

Peter Repiščák is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Peter Repiščák has authored 13 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Peter Repiščák's work include Prostate Cancer Treatment and Research (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Epigenetics and DNA Methylation (2 papers). Peter Repiščák is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Epigenetics and DNA Methylation (2 papers). Peter Repiščák collaborates with scholars based in United Kingdom, Austria and Finland. Peter Repiščák's co-authors include Martin J. Paterson, Stefan Erhardt, Graham Rena, I. Galbraith, Hing Y. Leung, Rachana Patel, Mark J. Salji, Ernest Mui, Heather A. Curry and Joanne Edwards and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Clinical Cancer Research.

In The Last Decade

Peter Repiščák

13 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Repiščák United Kingdom 9 225 105 68 53 40 13 402
Hongwei Guan China 14 315 1.4× 80 0.8× 60 0.9× 84 1.6× 41 1.0× 35 655
Huijiao Liu China 13 240 1.1× 143 1.4× 29 0.4× 42 0.8× 32 0.8× 23 447
Hongtao Chen China 13 267 1.2× 99 0.9× 40 0.6× 33 0.6× 26 0.7× 20 542
Jian Qin China 11 219 1.0× 93 0.9× 23 0.3× 60 1.1× 49 1.2× 21 442
Ji Eon Kim South Korea 14 223 1.0× 62 0.6× 60 0.9× 26 0.5× 41 1.0× 40 449
Ze Gong China 7 250 1.1× 125 1.2× 52 0.8× 101 1.9× 69 1.7× 10 532
Jinting Zhou China 13 311 1.4× 144 1.4× 41 0.6× 56 1.1× 38 0.9× 26 543
Shen‐Han Lee United Kingdom 9 206 0.9× 137 1.3× 21 0.3× 30 0.6× 22 0.6× 12 432
Jieping Zhang China 13 320 1.4× 128 1.2× 38 0.6× 148 2.8× 23 0.6× 37 555

Countries citing papers authored by Peter Repiščák

Since Specialization
Citations

This map shows the geographic impact of Peter Repiščák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Repiščák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Repiščák more than expected).

Fields of papers citing papers by Peter Repiščák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Repiščák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Repiščák. The network helps show where Peter Repiščák may publish in the future.

Co-authorship network of co-authors of Peter Repiščák

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Repiščák. A scholar is included among the top collaborators of Peter Repiščák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Repiščák. Peter Repiščák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Maurer‐Granofszky, Margarita, Raúl Jiménez Heredia, Clare E. Casey, et al.. (2025). Image-based drug screening combined with molecular profiling identifies signatures and drivers of therapy resistance in pediatric AML. Cell Reports Medicine. 6(9). 102304–102304. 1 indexed citations
2.
Malcomson, Thomas, Peter Repiščák, Stefan Erhardt, & Martin J. Paterson. (2022). Protocols for Understanding the Redox Behavior of Copper-Containing Systems. ACS Omega. 7(49). 45057–45066. 8 indexed citations
3.
Salji, Mark J., Arnaud Blomme, J. Henry M. Däbritz, et al.. (2022). Multi-omics & pathway analysis identify potential roles for tumor N-acetyl aspartate accumulation in murine models of castration-resistant prostate cancer. iScience. 25(4). 104056–104056. 6 indexed citations
4.
Kromp, Florian, Fikret Rifatbegovic, Peter Repiščák, et al.. (2021). Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging. Cancers. 13(17). 4311–4311. 20 indexed citations
5.
Shahin, Tala, Hye Sun Kuehn, Lisa Gawriyski, et al.. (2021). Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity. Science Immunology. 6(65). eabe3981–eabe3981. 23 indexed citations
6.
Malviya, Gaurav, Rachana Patel, Mark J. Salji, et al.. (2020). 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy. EJNMMI Research. 10(1). 143–143. 17 indexed citations
7.
Rushworth, Linda, Victoria Harle, Peter Repiščák, et al.. (2020). In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer. Life Science Alliance. 3(12). e202000770–e202000770. 14 indexed citations
8.
Patel, Rachana, Ernest Mui, Carolyn J. Loveridge, et al.. (2018). Targeting cholesterol transport in castration-resistant prostate cancer. Clinical Cancer Research. 24. 85–85. 1 indexed citations
9.
Patel, Rachana, Janis Fleming, Ernest Mui, et al.. (2018). Sprouty2 loss‐induced IL 6 drives castration‐resistant prostate cancer through scavenger receptor B1. EMBO Molecular Medicine. 10(4). 21 indexed citations
10.
Cameron, Amy, Lisa Logie, Kashyap Patel, et al.. (2017). Metformin selectively targets redox control of complex I energy transduction. Redox Biology. 14. 187–197. 117 indexed citations
11.
Repiščák, Peter, et al.. (2016). General Force-Field Parametrization Scheme for Molecular Dynamics Simulations of Conjugated Materials in Solution. Journal of Chemical Theory and Computation. 12(8). 3813–3824. 44 indexed citations
12.
Ahmad, Imran, Ernest Mui, Laura C.A. Galbraith, et al.. (2016). Sleeping Beautyscreen revealsPpargactivation in metastatic prostate cancer. Proceedings of the National Academy of Sciences. 113(29). 8290–8295. 87 indexed citations
13.
Repiščák, Peter, Stefan Erhardt, Graham Rena, & Martin J. Paterson. (2014). Biomolecular Mode of Action of Metformin in Relation to Its Copper Binding Properties. Biochemistry. 53(4). 787–795. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongwei Guan Breakdown of academic impact, for papers by Huijiao Liu Breakdown of academic impact, for papers by Hongtao Chen Breakdown of academic impact, for papers by Jian Qin Breakdown of academic impact, for papers by Ji Eon Kim Breakdown of academic impact, for papers by Ze Gong Breakdown of academic impact, for papers by Jinting Zhou Breakdown of academic impact, for papers by Shen‐Han Lee Breakdown of academic impact, for papers by Jieping Zhang
Rankless by CCL
2026